Ariel Castro

Ariel Castro

Auto-generated profile, based on publicly available information

Ariel Castro

Hospital Clínico Universidad de Chile, Facultad de Medicina, Universidad de Chile, Santiago, Chile

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 April 2018 in Journal of Medical Internet Research
Verified
Journal Article
Open access
GRGraciela Rojas
Graciela Rojas
VGViviana Guajardo
Viviana Guajardo
PMPablo Martinez
Pablo Martinez
ACAriel Castro
Ariel Castro
RFRosemarie Fritsch
Rosemarie Fritsch
SBStephanie Bauer
Stephanie Bauer
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet

1 February 2015 in Revista médica de Chile
Verified
Journal Article
Open access
GHGloria Horta
Gloria Horta
MLMarcelo López
Marcelo López
ADAndrés Dotte
Andrés Dotte
Jorge CorderoJorge Cordero
Jorge Cordero
CCCaterina Chesta
Caterina Chesta
JPJaime Poniachik
Jaime Poniachik
Multidetector computed tomography (MDCT) of the abdomen, with use of contrast medium, is able to detect and differentiate most focal liver lesions. To determine the prevalence and features of benign focal liver lesions (BFLL) detected by abdominal MDCT. We reviewed the reports of contrast abdominal MDCT performed to outpatients between August 2011 and July 2012. Clinical data of examined patients and imaging findings in terms of description of the hepatic parenchyma and the presence of BFLL, were recorded. Data from 1,184 studies were analyzed. Of these, 461 studies (38.4%) reported BFLL. The most prevalent lesions were simple cysts in 290 studies (24%) and hemangiomas in 61 studies (5.1%), granuloma-calcification in 39 (3.2%), focal nodular hyperplasia in 19 (1.6%) and one adenoma. If patients with known causes of liver disease were excluded, the prevalence of BFLL did not change substantially (lesions were found in 396 (37.5%) patients). Compared with livers with signs of damage, normal livers had more cystic lesions (27 and 16.2% respectively, p = 0.014) and hemangiomas (5.3 and 1.1% respectively, p = 0.043). BFLL are very common findings in MDCT studies. Most of these lesions are simple cysts and hemangiomas.

21 August 2017 in JMIR Preprints
Verified
Preprint
Open access
GRGraciela Rojas
Graciela Rojas
VGViviana Guajardo
Viviana Guajardo
PMPablo Martinez
Pablo Martinez
ACAriel Castro
Ariel Castro
RFRosemarie Fritsch
Rosemarie Fritsch
SBStephanie Bauer
Stephanie Bauer
BACKGROUND In the treatment of depression, primary care teams have an essential role, but they are most effective when inserted into a collaborative care model for disease management. In rural areas, the shortage of specialized mental health resources may hamper management of depressed patients. OBJECTIVE The aim was to test the feasibility, acceptability, and effectiveness of a remote collaborative care program for patients with depression living in rural areas. METHODS In a nonrandomized, open-label (blinded outcome assessor), two-arm clinical trial, physicians from 15 rural community hospitals recruited 250 patients aged 18 to 70 years with a major depressive episode (DSM-IV criteria). Patients were assigned to the remote collaborative care program (n=111) or to usual care (n=139). The remote collaborative care program used Web-based shared clinical records between rural primary care teams and a specialized/centralized mental health team, telephone monitoring of patients, and remote supervision by psychiatrists through the Web-based shared clinical records and/or telephone. Depressive symptoms, health-related quality of life, service use, and patient satisfaction were measured 3 and 6 months after baseline assessment. RESULTS Six-month follow-up assessments were completed by 84.4% (221/250) of patients. The remote collaborative care program achieved higher user satisfaction (odds ratio [OR] 1.94, 95% CI 1.25-3.00) and better treatment adherence rates (OR 1.81, 95% CI 1.02-3.19) at 6 months compared to usual care. There were no statically significant differences in depressive symptoms between the remote collaborative care program and usual care. Significant differences between groups in favor of remote collaborative care program were observed at 3 months for mental health-related quality of life (beta 3.11, 95% CI 0.19-6.02). CONCLUSIONS Higher rates of treatment adherence in the remote collaborative care program suggest that technology-assisted interventions may help rural primary care teams in the management of depressive patients. Future cost-effectiveness studies are needed. CLINICALTRIAL Clinicaltrials.gov NCT02200367; https://clinicaltrials.gov/ct2/show/NCT02200367 (Archived by WebCite at http://www.webcitation.org/6xtZ7OijZ)